
Hepatoblastoma is a sporadic liver cancer that mainly affects children aged one to three. Surgeons may be able to treat hepatoblastoma if it is detected, while liver cancer tumours are small enough to be entirely removed during surgery.
Timely treatment of hepatoblastoma, a rare liver cancer that mainly affects youngsters, is critical for improving survival rates. Early detection and timely management considerably improve the chances of successfully managing the condition and preventing its spread.
If treated early, the tumour can be surgically removed, and chemotherapy can be used to target any leftover cancer cells, lowering the risk of recurrence.
Delaying therapy can allow the cancer to develop, making it more difficult to cure and decreasing the likelihood of complete recovery. Timely therapy also increases overall survival rates and improves the quality of life for affected youngsters.
Common symptoms include:
Causes
Children are more likely to get hepatoblastoma if they:
Risk Factors
Risk factors include:
Complications
Hepatoblastoma is a rare cancer, and while there are no sure ways to prevent it, certain precautions may minimise risk factors or aid in early discovery. Here are some preventative tips:
They may combine surgery with the following treatments:
Chemotherapy: Providers may use chemotherapy to shrink tumours before surgery. Chemotherapy may be systemic or local.
Cost Start From USD 800 - USD 6000Explore Options
Transarterial chemoembolisation (TACE): Providers inject anti-cancer drugs into one of the arteries that supply blood to your child’s liver. Then, they inject a substance to block the artery.
Radiation therapy: Providers may use radiation therapy after surgery to remove any remaining cancer cells or as an alternative way to treat tumours that surgery can’t remove.
Ablation therapy: This treatment destroys or removes tissue. Providers use ablation therapy to treat recurring hepatoblastoma.
Liver transplantation: Your child’s surgeon may recommend a liver transplant if tumours in your child’s liver are too large to remove with surgery.
{liver-transplant}The tests include:
Rehabilitation following hepatoblastoma treatment is an essential part of the recovery process. It promotes a child's physical, emotional, and social well-being. The following are some rehabilitation alternatives for children recovering from hepatoblastoma:
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Sharjah, United Arab Emirates
Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-

Dubai, United Arab Emirates
Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing the United Arab Emirates:
The prognosis is determined by factors such as tumour size and spread, early detection, and the child's response to treatment. Survival rates are reasonable when treatment is administered on time and appropriately, particularly for circumscribed malignancies.
The five-year survival rate for hepatoblastoma in the United Arab Emirates is roughly 50%; results vary depending on metastasis and tumour resectability. Even though the survival rate is lower in the UAE than in other areas, pediatric patients' fortunes should improve with continued improvements in treatment approaches, early detection, and cutting-edge medicines.
While hepatoblastoma can recur after initial treatment, the risks of recurrence are reduced with effective surgery and chemotherapy. Regular follow-up treatment is necessary for the early detection of recurrence.
Family support is critical in treating children with hepatoblastoma. Emotional and psychological support, as well as financial and logistical assistance, can significantly improve the child's treatment outcomes. Support organisations and networks in the United Arab Emirates can also provide aid and comfort.
Indeed, there are specialised hepatoblastoma treatment facilities in the United Arab Emirates, especially in large hospitals with pediatric cancer departments. These facilities, including liver transplants, surgical resection, and sophisticated chemotherapy, offer comprehensive care. To ensure that patients receive individualised treatment programs and the most outstanding results for this uncommon and difficult ailment, they employ a comprehensive strategy.